Metastasis remains the primary cause of cancer-related mortality, driven largely by a cellular reprogramming process known as the epithelial-mesenchymal transition (EMT). During EMT, stationary epithelial cells lose their polarity and cell-cell adhesion, gaining the migratory and invasive properties of mesenchymal cells. Recent research has identified microRNAs (miRNAs)—small, non-coding RNA molecules—as central rheostats that tune this transition by targeting critical signaling nodes.
MicroRNAs as Suppressors of Metastatic Signaling
In many aggressive cancers, specific miRNAs function as tumor suppressors by silencing the genes that drive EMT. These miRNAs act as molecular "brakes," preventing the activation of pathways that allow cells to break away from the primary tumor.
For instance, in hepatocellular carcinoma, Yong Wang et al. demonstrated that miR-26b-5p targets SMAD1, a key mediator of the TGF-β signaling pathway, to inhibit EMT and invasion. Similarly, in prostate cancer, Bao‐Gang Sun et al. found that miR-539 suppresses the TGF-β/Smad4 axis by down-regulating the homeobox protein DLX1.
These suppressive effects are observed across diverse malignancies:
- Gastric Cancer: Jun Liu et al. showed that miR-144 inhibits metastasis by targeting the MET proto-oncogene.
- Colorectal Cancer: Wenhua Li et al. identified miR-99b-5p as a suppressor of liver metastasis through the down-regulation of mTOR.
- Cervical Cancer: Jinchang Huang et al. reported that miR-125a attenuates malignant behavior by targeting the DNA repair protein Rad51.
Oncogenic MicroRNAs and Regulatory Loops
Conversely, some miRNAs function as oncogenes (oncomiRs) by silencing the inhibitors of EMT. This creates a permissive environment for cancer cell migration. Jisheng Hu et al. discovered that in pancreatic ductal adenocarcinoma, miR-361-3p promotes EMT by degrading DUSP2 mRNA, which in turn activates the ERK1/2 signaling pathway. In renal cancer, Jianzhou Cui et al. found that miR-196a targets BRAM1, disrupting SMAD and MAPK signaling to favor invasion.
Beyond simple linear targeting, miRNAs can participate in self-reinforcing feedback loops that lock cells into a metastatic state. Pai Pang et al. described a positive feedback loop between the transcription factor SP1 and miR-92b in head and neck squamous cell carcinoma, where each component drives the expression of the other to sustain tumor progression.
The Intersection of miRNAs and m6A Methylation
A sophisticated layer of this regulatory axis involves the interaction between miRNAs and the RNA epitranscriptome. The stability of mRNAs is often determined by $N^6$-methyladenosine ($m^6A$) modifications, which are added by "writer" enzymes like METTL3.
X. Su et al. recently uncovered a regulatory axis in pancreatic cancer where miR-33a-3p directly targets METTL3. By reducing METTL3 levels, the miRNA prevents the $m^6A$-mediated stabilization of the oncogene AREG. This finding is significant because it suggests that miRNAs do not just target downstream effectors of EMT, but also regulate the epigenetic machinery that controls the stability of the entire metastatic transcriptome.
Conclusion
The evidence across these studies suggests that the "microRNA-EMT axis" is not a single pathway but a complex network of switches. Whether acting as suppressors that target growth factor receptors (MET) and signaling mediators (SMADs), or as oncogenes that silence phosphatases (DUSP2) and epigenetic writers (METTL3), miRNAs serve as the critical software controlling the hardware of cancer cell mobility. Understanding these specific interactions provides a roadmap for developing targeted therapies that could potentially "reset" the metastatic program in advanced cancers.
Key Foundational Work
Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma (2016) — contributed 4 concept elements to this direction.
MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression (2015) — contributed 1 concept elements to this direction.
miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR (2015) — contributed 1 concept elements to this direction.